Image

AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer

AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer

Recruiting
18-90 years
All
Phase N/A

Powered by AI

Overview

The goal of this observational study is to develop and validate a deep learning model to dynamically assess postoperative bleeding risk and assist in decision-making for re-operation in adult patients (≥18 years) diagnosed with primary gastric cancer undergoing radical gastrectomy. The main question\[s\] it aims to answer \[is/are\]:

Can an AI model based on perioperative dynamic physiological parameters and precise intraoperative blood loss accurately predict the risk of postoperative bleeding requiring re-operation? Does the application of this AI model improve clinical decision-making (e.g., earlier warning time, optimal intervention timing) and patient outcomes (e.g., mortality, length of stay)? Since there is no comparison group (this is a pure observational study without intervention arms), researchers will not compare different treatment groups. Instead, the investigators will evaluate the model's performance (sensitivity, negative predictive value, AUC, calibration) using retrospective data for training and prospective multi-center data for external validation.

Participants will:

Undergo standard radical gastrectomy and routine postoperative care as per clinical practice (no study-specific interventions).

Have their perioperative data collected, including demographics, medical history, vital signs, laboratory tests (blood gas analysis), surgical details, and precise intraoperative blood loss measurements.

(For prospective participants only) Provide informed consent and complete follow-up assessments up to 30 days post-surgery.

Description

This study employs a hybrid design, collecting both retrospective and prospective data.

Eligibility

Inclusion Criteria:

  1. Age: Patients aged ≥ 18 years.
  2. Diagnosis: Histologically confirmed primary gastric cancer.
  3. Surgical Procedure: Underwent radical gastrectomy (including proximal, distal, or total gastrectomy).
  4. Consent: Provision of written informed consent (required specifically for the prospective phase).
  5. Data Completeness: Availability of complete preoperative clinical data and postoperative follow-up records covering at least the first 15 days post-surgery.
  6. Oncological History: No history of other primary malignant tumors.

Exclusion Criteria:

  1. Surgical Type: Patients who underwent non-radical resection or emergency surgery.
  2. Data Quality: Missing rate of key data fields exceeds 20%.
  3. Preoperative Condition: Presence of severe preoperative infection or organ failure.
  4. Follow-up Compliance: Unwillingness to participate in prospective follow-up or inability to complete the follow-up schedule (applicable only to the prospective phase).

Study details
    Gastrectomy for Gastric Cancer
    Gastric Cancer

NCT07525765

First Affiliated Hospital of Zhejiang University

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.